Table 1.
PitNET subtypes identified by the immunohistochemical and molecular studies in the present series.
Table 2.
Classification and prevalence of the different PitNET subtypes according to their clinical (functioning and silent), molecular and IHC identification.
Fig 1.
Linear regression between PRL gene expression in seven functioning lactotropinomas and the dose of cabergoline administered prior to surgery.
Table 3.
Concordance between IHC and molecular identification of subtypes of functioning PitNET with clinical diagnosis.
Table 4.
Concordance between molecular and IHC identification in functioning and silent variants of PitNET.
Table 5.
Concordance between molecular and IHC identification of functioning PitNET subtypes with clinical diagnosis in the present series and in the previous one.
Table 6.
Concordance between molecular and IHC identification in silent functioning PitNET subtypes in the present series and in the previous one.